MABCURE INC. INVESTMENT AGREEMENTInvestment Agreement • January 20th, 2011 • Mabcure Inc. • In vitro & in vivo diagnostic substances • Georgia
Contract Type FiledJanuary 20th, 2011 Company Industry JurisdictionTHIS INVESTMENT AGREEMENT DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF AN OFFER TO PURCHASE, ANY OF THE SECURITIES DESCRIBED HEREIN BY OR TO ANY PERSON IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES AUTHORITIES, NOR HAVE SUCH AUTHORITIES CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 20th, 2011 • Mabcure Inc. • In vitro & in vivo diagnostic substances • Georgia
Contract Type FiledJanuary 20th, 2011 Company Industry JurisdictionThis Registration Rights Agreement (this "Agreement"), dated as of January 18, 2011, by and between MabCure, Inc., a Nevada corporation (the "Company"), and Centurion Private Equity, LLC, a limited liability company organized under the laws of the state of Arizona (”Investor” or the “Holder”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 20th, 2011 • Mabcure Inc. • In vitro & in vivo diagnostic substances • Georgia
Contract Type FiledJanuary 20th, 2011 Company Industry JurisdictionSECURITIES PURCHASE AGREEMENT (this "Agreement," “Purchase Agreement,” or “Securities Purchase Agreement”), dated as of January 18, 2011, by and among MabCure, Inc., a Nevada corporation, ("Company"), and Centurion Private Equity, LLC, a Georgia Limited Liability Company ( “Buyer”).